What is the severity of CVE-2017-14111?

CVE-2017-14111 is classified as a high severity vulnerability due to the potential unauthorized access to sensitive authentication credentials.

How do I fix CVE-2017-14111?

To mitigate CVE-2017-14111, users should upgrade Philips IntelliSpace Cardiovascular to version 2.4.0 or later and Phillips Xcelera to version R4.1L2 or later.

What are the affected versions for CVE-2017-14111?

CVE-2017-14111 affects Philips IntelliSpace Cardiovascular versions up to 2.3.0 and Philips Xcelera versions up to R4.1L1.

What risk does CVE-2017-14111 pose?

CVE-2017-14111 poses a risk of attackers gaining access to domain authentication credentials, leading to unauthorized access to the application and user data.

Is there a workaround for CVE-2017-14111?

Currently, the best workaround for CVE-2017-14111 is to ensure proper access controls and monitor logging functions until the software is upgraded.

Vulnerability/
CVE-2017-14111

high

7.2

CWE

522

17/11/2017

5/8/2024

CVE-2017-14111

First published: Fri Nov 17 2017(Updated: )

The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements.

Credit: cve@mitre.org

Affected Software	Affected Version	How to fix
Philips IntelliSpace Cardiovascular	<=2.3.0
Philips Xcelera	<=r4.1l1

Never miss a vulnerability like this again

Reference Links

Frequently Asked Questions

What is the severity of CVE-2017-14111?
CVE-2017-14111 is classified as a high severity vulnerability due to the potential unauthorized access to sensitive authentication credentials.
How do I fix CVE-2017-14111?
To mitigate CVE-2017-14111, users should upgrade Philips IntelliSpace Cardiovascular to version 2.4.0 or later and Phillips Xcelera to version R4.1L2 or later.
What are the affected versions for CVE-2017-14111?
CVE-2017-14111 affects Philips IntelliSpace Cardiovascular versions up to 2.3.0 and Philips Xcelera versions up to R4.1L1.
What risk does CVE-2017-14111 pose?
CVE-2017-14111 poses a risk of attackers gaining access to domain authentication credentials, leading to unauthorized access to the application and user data.
Is there a workaround for CVE-2017-14111?
Currently, the best workaround for CVE-2017-14111 is to ensure proper access controls and monitor logging functions until the software is upgraded.

collector/nvd-index
agent/type
agent/softwarecombine
collector/mitre-cve
source/MITRE
agent/severity
agent/weakness
agent/references
agent/author
agent/last-modified-date
agent/tags
agent/description
agent/first-publish-date
agent/event
agent/source
vendor/philips
canonical/philips intellispace cardiovascular
version/philips intellispace cardiovascular/2.3.0
canonical/philips xcelera
version/philips xcelera/r4.1l1

Company

Resources

Contact

SecAlerts Pty Ltd.
132 Wickham Terrace
Fortitude Valley,
QLD 4006, Australia
info@secalerts.co

By using SecAlerts services, you agree to our services end-user license agreement. This website is safeguarded by reCAPTCHA and governed by the Google Privacy Policy and Terms of Service. All names, logos, and brands of products are owned by their respective owners, and any usage of these names, logos, and brands for identification purposes only does not imply endorsement. If you possess any content that requires removal, please get in touch with us.